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Introduction
Brachial plexopathy-associated breast cancer can occur by radiation injury or metastatic spread of the tumor [1] . This plexopathy can be detected by short tau inversion recovery (STIR) magnetic resonance (MR) imaging (MRI) and fluorodeoxyglucose positron-emission tomography (PET) [2, 3] . On the other hand, metastasis of breast cancer is often detected through a long-term course and difficult to diagnose [4] . Here, we report a case of brachial plexopathy suspected to be the initial lesion of breast cancer metastasis, which was only detected by MR neurography.
Case and Discussion
A 61-year-old woman was admitted to our hospital within 2 years after operation for breast cancer (invasive ductal carcinoma, T2N0M0, stage IIA) because of progressive dysesthesia and motor weakness initially in the upper limb on the affected side and subsequently on the contralateral side. Laboratory findings showed no elevation of autoantibodies (including anti-ganglioside antibodies and anti-neural antibodies) or tumor markers [carcinoembryonic antigen 1.7 ng/ml, carbohydrate antigen (CA) 15-3 22.0 U/ml]. Cerebrospinal fluid (CSF) also showed no elevation of protein and pleocytosis and class I of cytology. Electromyographic study showed the extension with the motor conduction velocity on the left side of median (42.8 m/s) and ulnar (47.5 m/s) nerves. Compound muscle action potentials were normal and conduction block was not shown. Sensory nerve action potentials were absent. Needle electromyography showed neurogenic changes along with the voluntary movement on the upper extremities and denervation potential at rest. Enhanced computed tomography, axillary lymph node echo, gallium scintigraphy, and STIR MRI images showed no abnormalities ( fig. 1) . MR neurography, which can detect nerve swelling and edema [5] , revealed a swollen region in the left brachial plexus ( fig. 2 ). At first, we suspected neuralgic amyotrophy and initiated treatment with intravenous immunoglobulin therapy and steroid therapy. However, there was no improvement, and motor weakness gradually progressed and also appeared in the lower limbs over 4 years. Concomitant elevation of CA15-3 level (58.9 U/ml) led us to suspect breast cancer metastasis, which was associated with the worsening of neurological findings, although gallium scintigraphy and bone scintigraphy showed no inflammatory and metastatic lesions. On the other hand, CSF showed elevated protein (465 mg/dl) and pleocytosis (11/mm 3 ) in parallel with the increased CA15-3 levels. Cytology also showed class III with atypical cells. Swelling of the cauda equina in enhanced lumbar MRI ( fig. 3 ) and abnormal accumulation at the brachial plexus and cervical spinal cord in PET ( fig. 4) were newly detected contrary to the normal findings on the gallium scintigraphy, which suggested CSF seeding. As reported previously about the high false-negative rate of malignant cells by CSF cytology [6] , we could not detected metastatic malignant cells in CSF. But the abnormal lesions in enhanced MRI [7] and PET suggested malignant tumor. We suspected as the initial brachial plexopathy due to breast cancer metastasis based on the clinical course; CSF seeding and the elevation of CA15-3 in parallel with the worsening of brachial plexopathy. Although STIR imaging did not show abnormal findings in our case, MR neurography may be a helpful tool to detect metastatic lesion, especially in nerve roots [8] .
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